Cyclin D3 gene amplification in bladder carcinoma in situ
✍ Scribed by Antonio Lopez-Beltran; Jose L. Ordóñez; Ana P. Otero; Ana Blanca; Vicky Sevillano; Marta Sanchez-Carbayo; Elisa Muñoz; Liang Cheng; Rodolfo Montironi; Enrique de Alava
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 284 KB
- Volume
- 457
- Category
- Article
- ISSN
- 1432-2307
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Cyclin D1 (CCND1) amplification is found in 10-15 per cent of invasive breast carcinomas, but it is not well established whether this gene alteration also occurs in the precursor of invasive breast carcinoma, ductal carcinoma in situ (DCIS). By Southern blot analysis, cyclin D1 gene amplification wa
## The genetic changes of cyclin A, DI, E and CDK2 were examined in human colorectal carcinomas by Southern-blot analysis. Gene amplification of cyclin E was detected in 5 of 53 (9.4%) primary colorectal carcinoma tissues. Interestingly, in 3 of 5 tumors showing cyclin E gene amplification, the CD
## Abstract The cyclin D1 gene, __CCND1__, located within chromosome 11q13, plays an important role in the regulation of cell‐cycle progression and has oncogenic properties. Cyclin D1 frequently is overexpressed in a variety of cancers, including hepatocellular carcinoma (HCC), as a result of gene